Cardium Therapeutics, Inc. (CXM) - Medical Equipment - Deals and Alliances Profile

Date: February 12, 2014
Pages: 50
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CCBC99F83D1EN
Leaflet:

Download PDF Leaflet

Cardium Therapeutics, Inc. (CXM) - Medical Equipment - Deals and Alliances Profile
Summary

Cardium Therapeutics, Inc. (Cardium) is an asset-based, health sciences and regenerative medicine company. The company focuses on the acquisition and development of innovative products and businesses. Its major portfolio companies include Tissue Repair Company, Cardium Biologics and To Go Brands, Inc. Its flagship product Excellagen topical gel is used for wound care management. These companies undertake the development of therapeutic products for cardiovascular indications; wound healing and healthy nutraceutical supplement business. Its lead product is an FDA approved Excellagen topical gel, used for wound care management; and its Generx, is a DNA-based angiogenic biologic. Cardium markets its products through third party collaborations throughout the world. Cardium is headquartered in San Diego, California, the US.

Cardium Therapeutics, Inc. (CXM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Cardium Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deal Details
Partnerships
Cardium Therapeutics Enters Into Distribution Agreement With Kasiak Holding For Excellagen
Cardium Enters Into Distribution Agreement With AvKare For Excellagen
Equity Offering
Cardium Therapeutics Completes Second Tranche Of Private Placement Of Preferred Stock For US$1.7 Million
Cardium Therapeutics Completes Private Placement Of Common Stock For US$5 Million
Cardium Therapeutics Completes Private Placement Of Shares For US$0.8 Million
Cardium Therapeutics Completes Registered Direct Offering Of Units For US$11.3 Million
Cardium Therapeutics Completes Registered Direct Offering Of US$6 Million
Cardium Therapeutics Completes Private Placement Of US$4.5 Million
Cardium Therapeutics Completes Private Placement Of US$3.3 Million
Cardium Therapeutics Completes Private Placement Of US$3.2 Million
Cardium Therapeutics Completes US$5.3 Million Registered Direct Offering
Debt Offering
Cardium Therapeutics Completes Private Placement Of US$6 Million
Acquisition
Philips Healthcare Completes Acquisition Of INNERCOOL therapies From Cardium Therapeutics
Cardium Therapeutics, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Nov 19, 2013: Cardium reports on third quarter 2013 financial results and recent business developments
Aug 14, 2013: Cardium Reports On Second Quarter 2013 Financial Results And Recent Business Developments
May 15, 2013: Cardium Therapeutics Reports Q1 2013 Results
Apr 05, 2013: Cardium Therapeutics Reports 2012 Results
Corporate Communications
Jan 24, 2014: Cardium Common Stock To Begin Trading On The OTCQB Market
Dec 20, 2013: Cardium Provides Update On Exchange Listing
Oct 07, 2013: Cardium Provides Update On Exchange Listing
Jan 16, 2013: Cardium Announces Acceptance Of Exchange Listing Compliance Plan By NYSE MKT
Product News
Jan 27, 2014: Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings
Dec 04, 2013: Cardium's Excellagen Assigned Q Code For Product Reimbursement
Aug 05, 2013: Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties
Mar 14, 2013: Cardium Receives ISO Certification From BSI For Excellagen
Feb 14, 2013: CARDIUM’S EXCELLAGEN AWARDED AMERICAN PODIATRIC MEDICAL ASSOCIATION SEAL OF APPROVAL
Jan 03, 2013: Cardium Announces Sales and Distribution Agreement With Academy Medical To Promote Excellagen Clinical Adoption By US Government Medical Providers
Product Approvals
Feb 14, 2013: CARDIUM’S EXCELLAGEN AWARDED AMERICAN PODIATRIC MEDICAL ASSOCIATION SEAL OF APPROVAL
Clinical Trials
Jan 27, 2014: Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Cardium Therapeutics, Inc., Medical Equipment, Key Facts, 2012
Cardium Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
Cardium Therapeutics, Inc., Deals By Market, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
Cardium Therapeutics Enters Into Distribution Agreement With Kasiak Holding For Excellagen
Cardium Enters Into Distribution Agreement With AvKare For Excellagen
Cardium Therapeutics Completes Second Tranche Of Private Placement Of Preferred Stock For US$1.7 Million
Cardium Therapeutics Completes Private Placement Of Common Stock For US$5 Million
Cardium Therapeutics Completes Private Placement Of Shares For US$0.8 Million
Cardium Therapeutics Completes Registered Direct Offering Of Units For US$11.3 Million
Cardium Therapeutics Completes Registered Direct Offering Of US$6 Million
Cardium Therapeutics Completes Private Placement Of US$4.5 Million
Cardium Therapeutics Completes Private Placement Of US$3.3 Million
Cardium Therapeutics Completes Private Placement Of US$3.2 Million
Cardium Therapeutics Completes US$5.3 Million Registered Direct Offering
Cardium Therapeutics Completes Private Placement Of US$6 Million
Philips Healthcare Completes Acquisition Of INNERCOOL therapies From Cardium Therapeutics
Cardium Therapeutics, Inc., Key Competitors
Cardium Therapeutics, Inc., Key Employees
Cardium Therapeutics, Inc., Subsidiaries

LIST OF FIGURES

Cardium Therapeutics, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
Cardium Therapeutics, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

Cardium Therapeutics, Inc. (CXM) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: